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Dichotomy between the 
transcriptomic landscape of 
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thomas thum5,6, Martine de Boer7, Dirk J. Duncker  7, Blanche Schroen2,  
Anne-Sophie Armand8, Monika Stoll4,9 & Leon J. De Windt  1,2 ✉
We investigated the transcriptomic landscape of the murine myocardium along the course of natural 
aging and in three distinct mouse models of premature aging with established aging-related cardiac 
dysfunction. Genome-wide total RNA-seq was performed and the expression patterns of protein-
coding genes and non-coding RNAs were compared between hearts from naturally aging mice, mice 
with cardiac-specific deficiency of a component of the DNA repair machinery, mice with reduced 
mitochondrial antioxidant capacity and mice with reduced telomere length. Our results demonstrate 
that no dramatic changes are evident in the transcriptomes of naturally senescent murine hearts until 
two years of age, in contrast to the transcriptome of accelerated aged mice. Additionally, these mice 
displayed model-specific alterations of the expression levels of protein-coding and non-coding genes 
with hardly any overlap with age-related signatures. Our data demonstrate very limited similarities 
between the transcriptomes of all our murine aging models and question their reliability to study 
human cardiovascular senescence.
The perception of old age as a merciless and unavoidable perpetrator of the decay of the human body has been 
a common theme among ancient and modern artists. Oscar Wilde in his novel “The Picture of Dorian Gray” 
conveys the idea of the fading of youth coming with age as a despicable plague, as an illness consuming the body. 
Even the geneticist Richard Benedict Goldschmidt, yet with less harsh and colorful images, described aging as 
the unresolved, ultimate disease of the body; of Goldschmidt are the words “I have accumulated a wealth of 
knowledge in innumerable spheres and enjoyed it as an always ready instrument for exercising the mind and 
penetrating further and further. Best of all, mine has been a life of loving and being loved. What a tragedy that all 
this will disappear with the used-up body!”1.
From a biological perspective, aging still remains an unresolved dilemma: it is generally regarded as a complex 
process resulting from several causes, as epigenetic, proteotoxic and oxidative stresses, telomere shortening and 
unresolved DNA damages, all synergistically contributing to altering the functionality of cells, organs and ulti-
mately of the entire organism2–6.
The most recent theories on aging hypothesize that the ultimate responsible for organismal senescence is the 
cumulative contribution of damages to DNA, proteins, lipids and organelles, produced either by intrinsic stress, 
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such as reactive oxygen species (ROS) and reactive nitrogen species (RNS), or by extrinsic stress, such as UV light, 
irradiation and exposure to toxins, and together with other factors, namely genetic predisposition, epigenetic 
alterations, diet and physical activity7.
A big hurdle when studying the process of senescence is the choice of the model system to use. Longitudinal 
and cross-sectional studies on human aging are merely observational and not mechanistic in nature, thus making 
unavoidable the use of model organisms. For this purpose, rodents represent the unsurpassed gold-standard: 
mice and rats have a relative short lifespan (approximatively two years) which makes them easier to be used 
rather than long-lived animals8. Additionally, they offer the convenient advantage of genetic manipulation, which 
have resulted in the generation of the so-called “accelerated aging models”, carrying mutations that affect one or 
more of the pathways generally associated with physiological aging or reproducing human genetic afflictions of 
accelerated aging. The use of model organisms has however its downside: it is nearly impossible to tell whether an 
organism is representative of human aging or not since it is not known if the aging-related mechanisms operating 
across different species are conserved. This can cause pitfalls in the interpretation of the translational value of the 
findings in the current model organisms.
The constant increase in life expectancy together with low birth rates had caused a dramatic increase in 
the median age of the European population, making a better understanding of the aging process of critical rel-
evance. In particular, studying the aging of the heart has become of great value, since among the elderly the 
prevalence of cardiovascular diseases is greatly enhanced. Indeed, with increasing age the prevalence of cardi-
ovascular risk factors, such as metabolic syndromes sharply increases, promoting atherosclerosis and ischemic 
heart disease9. Preceding these structural modifications are changes in the “genomics” of the heart, as fluctua-
tions in transcript abundance of protein-coding and non-coding genes and the re-expression of genes that are 
typically observed in the heart at the fetal stage10,11. A better understanding of the mechanisms driving the sus-
ceptibility to these pathologies is likely to be found by diving more in depth into the genomics of the heart. The 
efforts of the International Human Genome Sequencing Consortium (2004) have surprisingly revealed that the 
human genome encodes only 19,438 known protein-coding genes, accounting for about the 2% of total genomic 
sequence. Nonetheless, results from the Encyclopedia of DNA Elements (ENCODE) project reveals that at least 
80% of this remaining non-coding fraction is functional, has a regulatory role and is transcribed into various 
classes of non-coding RNAs (ncRNAs)12.
Here, we investigated the genomic features of the aging murine myocardium. To this end, by total 
RNA-sequencing we charted the changes occurring in the transcriptome of murine heart tissue, taking into con-
sideration both its protein-coding and non-coding fractions. To decipher the particulars of the aging process in 
the heart, we included cardiac tissue derived from a mouse model of natural aging and hearts from no less than 
three different mouse models of premature senescence, namely the heart-specific Ercc1-deficient model, charac-
terized by an impaired DNA-repair machinery, the Tert-deficient model, lacking telomerase activity resulting in 
reduced telomere length, and the Harlequin (Hq) model that has increased vulnerability to oxidative stress. This 
last model is of particular interest for the variety of phenotypes that it develops, such as accelerated progression 
to heart failure in response to stress, sarcopenia and neurodegenerative changes13. Our results show a surprisingly 
high stability of the transcriptome of naturally aged mice throughout their lifespan and a remarkably small over-
lap of these expression patterns with those of the accelerated aging mouse models. Overall, we observed striking 
dissimilarities between prematurely aged mouse models and natural aging, which may raise doubts about the 
applicability of these models to the study of the genomics of human myocardial senescence.
Methods
Mouse models. The mouse models we used include a model of natural aging and three different models of 
accelerated aging, particularly mice with cardiac-specific deficiency of the Excision repair cross-complementation 
group 1 (Ercc1), mice with reduced mitochondrial antioxidant capacity and Telomerase Reverse Transcriptase 
(Tert) deficient mice with reduced telomere length. Further details for each model are discussed below.
Male and female wild-type B6129F1 mice 12-, 52- and 104 weeks old were included as models of natural aging: 
the specific ages have been chosen to represent the young (12 weeks), adult (52 weeks) and old (104 weeks) phases 
of the murine lifespan. Wild-type B6129F1 mice show normal development and only in the oldest mice (104 
weeks of age), mild signs of eccentric remodeling with fibrosis and slightly reduced contractility are evident14.
The first model of accelerated aging we included in the study is the one we address as the Harlequin (Hq) 
model: these are male mice on a B6CBACa-Aw-J/A (B6CBA) background between 17 and 20 weeks of age which 
present a proviral insertion in the first intron of Apoptosis inducing factor mitochondria associated 1 (Aifm1) 
in hemizygosity that reduces for the 80% the expression of this gene15. This gene encodes for the flavoprotein 
AIFM1: it is normally localized at the mitochondrial intermembrane space level where it plays a pro-survival 
role as free radical scavenger. These animals show clearly altered phenotypes, from neuronal loss, progressive 
retinal degeneration, ataxia to a reduced lifespan to less than 6 months, but no manifested cardiac abnormal-
ities, apart from an increase in heart to body weight ratio16. When subjected to ischemia/reperfusion injuries, 
however, Hq mice show an increased cardiomyocyte apoptotic and necrotic death and accelerated progression 
towards maladaptive left ventricular remodeling if compared to wild-type animals16. This model is particularly 
relevant for aging since intrinsic oxidative stress increases with age in the heart, due to age-related impairment of 
transcriptional responses to oxidant stress, diminished expression of antioxidant defense enzymes such as cata-
lase, glutathione peroxidase and MnSOD, increased myocardial expression of NADPH oxidases, culminating in 
age-dependent cardiac mitochondrial dysfunction17–20.
Another model of accelerated senescence we used for our study is the Ercc1 heart-specific knock-out one: to 
establish this model, mice harboring a floxed allele of Ercc1 in a 129P2/OlaHsd genetic background were cross-
bred with mice harboring Cre recombinase under control of the murine Myh6 promoter in a C57BL/6 J back-
ground. For our purposes, we selected male animals of 16 weeks of age. As one of the main components of the 
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nucleotide excision repair complex, Ercc1 is required for removing UV-induced DNA damages and inter-strand 
crosslinks21. Mice carrying the full-body knock-out of this protein show a very severe phenotype, with impaired 
growth and markedly reduced lifespan to a maximum of 8-10 weeks22,23; the heart-specific Ercc1-deficient mice 
we used in the present study show a milder phenotype than the one just described, a normal growth, a longer 
lifespan (maximum 23 weeks of age) and spontaneous cardiac alterations leading to dilated cardiomyopathy 
occurring over the first 16 weeks of life (unpublished observations Martine de Boer and Dirk Duncker).
The last progeroid model we used is the Tert knock-out mouse model: these animals are on a C57BL/6 J genetic 
background and were sacrificed at 16 weeks of age. In order to observe critical telomere shortening we used the 
third generation (G3) obtained after crossbreeding24,25. The TERT protein complex is responsible for de novo 
addition of telomeric repeats at the ends of chromosomes; in mice and humans, telomerase is normally silenced 
after birth. As a consequence, a slow, progressive telomere shortening is observed throughout the lifespan that 
subsequently triggers cellular senescence and apoptosis-related pathways26–28. Tert-deficient mice interbred for 
four generations (G4) to lower telomere reserves manifest ventricular dilation, ventricular wall thinning and car-
diac dysfunction29. Mice used in the current study are of the third generation (G3), which have a less pronounced 
and milder cardiac phenotype as described for G4 Tert-deficient mice (unpublished observations Christian Bär).
All protocols were performed according to institutional guidelines and approved by local Animal Care 
and Use Committees. Specifically, these authorities included the institutional animal care and user commit-
tee of the Lower Saxony State Office for Consumer Protection and Food Safety in Germany (license number 
2017/143), the Institutional animal care and use committee at Université Paris Descartes (Plateforme d’héberge-
ment et d'élevage des Saints-Pères, license number C 75-06-07) and the Dutch Central Committee of Animal 
Use (CCD) and Institutional animal care and user committees at Erasmus MC and Maastricht University in 
accordance with the respective National Authorities in Germany, France and the Netherlands and guidelines 
based on European Union Directive 2010/63/EU. All mice were housed on a 12 hr light:12 hr light:dark cycle in 
a temperature-controlled environment with ad libitum access to water and chow with a quarterly animal health 
monitoring system that complies with FELASA guidelines and recommendations. Randomization of subjects to 
experimental groups was based on a single sequence of random assignments. Animal caretakers blinded investi-
gators to animal group allocation before NGS sequencing and/or when assessing the outcome.
RNA isolation. Total RNA was extracted from myocardial tissue of mice euthanized at the timepoints 
reported above using the Direct-zol™ RNA MiniPrep method (Thermofisher) following the manufacturer’s 
protocol.
RNA sequencing. All samples were prepared simultaneously during all steps of this analysis in order to 
exclude introduction of technical variability. Quality control of total RNA was performed using the RNA 6000 
Pico Kit (Agilent Bioanalyzer) yielding in RIN values of 6.3 and higher. Removal of rRNA was carried out by use 
of the NEBNext rRNA Depletion Kit Human/Mouse/Rat (NEB) followed by strand-specific cDNA NGS library 
preparation (NEBNext Ultra II Directional RNA Library Prep Kit for Illumina, NEB). The size of the result-
ing library was controlled by use of a D1000 ScreenTape (Agilent 2200 TapeStation) and quantified using the 
NEBNext Library Quant Kit for Illumina (NEB). Equimolar pooled libraries were sequenced in a paired end 
mode (75 cycles) on the NextSeq. 500 System (Illumina) using v2 chemistry yielding in an average QScore distri-
bution of 84%>= Q30 score. After quality control with FastQC v0.11.230 raw sequencing data was read trimmed 
using trimmomatic v0.3631 and aligned to the mouse reference genome GRCm38 (ensemble release 90) with 
hisat2 v2.1.032. Overall alignment rate was observed between 70–84% for all samples. Gene assembly was done 
using stringtie v1.3.4d33 with set ‘-e’ parameter to produce read count matrices for reference genes and transcripts. 
The complete RNA-seq data sets from this study were deposited at the Gene Expression Omnibus (GEO) with ref-
erence GSE124087 in MINSEQ-compliant data submission format under restricted release date and will become 
publicly available pending acceptance of the current manuscript.
cDNA synthesis. Reverse transcription of the total RNA was performed using M-MLV (Promega) with oli-
go(dT) primers (Invitrogen) and random hexamers (IDT) following the manufacturer’s protocol.
Real-Time PCR. Real-time PCR was performed on a Bio-Rad iCycler (Bio-Rad) using SYBR Green. 
Transcript quantities were compared using the relative Ct method, where the amount of target is normalized to 
the amount of endogenous control (L7) and expressed relative to the control sample (12 week-old naturally aged 
animals) as 2−ΔΔCt. The sets of primers used are reported in Supplementary Table 1.
Differential expression analysis and statistical analysis. After evaluation of principal component 
analysis, two samples showed outlier characteristics. Because this could not have been explained by technical 
differences, all samples were used for further analysis for better transparency. Differential expression analysis was 
performed using the DESeq2 R-package version 1.20.034 applied on the gene count matrix obtained from string-
tie. The count matrix was normalized for library size and lowly expressed genes (minimum rowsum <10) have 
been removed from the dataset. Gene biotypes were annotated using the R annotation package org.Mm.eg.db ver-
sion 3.6.0. All analyses have been applied to the full data set as well as to data subsets containing protein-coding 
genes or lncRNA genes only. Genes were considered as significantly differentially expressed if the corresponding 
absolute fold change was greater than 1.5 and the differential expression P-value was less than 0.05 after adjust-
ment for false discovery rate according to the method of Benjamini and Hochberg. Expressed genes were analyzed 
in an over-representation analysis for enrichment of Reactome pathways and gene ontology (GO) terms using 
the top 100 differentially expressed genes, as it’s implemented in the clusterProfiler package version 3.8.135. The 
top 5 enriched GO terms of each analysis have been visualized with their corresponding genes as gene-concept 
networks using the cnetplot function of clusterProfiler.
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The results of the Real-time PCR analysis are presented as mean ± SEM. Statistical analyses 
were performed using Prism software (GraphPad Software), and consisted of ANOVA followed by Bonferroni’s 
multiple-comparison test when group differences were detected at the 5% significance level or Student’s t test 
when comparing two experimental groups. Differences were considered significant when p < 0.05.
Principal component analysis and hierarchical clustering. Further downstream analysis was per-
formed on variance stability transformed count data. Principal Component Analysis (PCA) was performed to 
broadly understand the gene expression relationship between models and visualize sample clustering for the 
most variably expressed genes. Loading scores and explained variance for the first two principal components 
were calculated and PCA plots were generated using the plotPCA function implemented in DESeq2. Heatmaps 
were produced using the significant genes of each group comparison and hierarchical clustering. Heatmap plots 
was generated using the heatmap.2 function in the R package gplots. Row Z scores were calculated for better gene 
expression comparison between samples, meaning that for each gene, the average intensity across all samples 
is set to zero and standard deviation is set to 1. A color code of + −1 means + − 1 standard deviation from the 
mean. The dendrogram was constructed based on the average distant algorithm implemented in heatmap.2.
Results
The transcriptome remains relatively stable in the naturally aged myocardium. To study the 
effects of natural aging on the genomic features of the heart, we performed total RNA sequencing on hearts from 
naturally aged mice of 12, 52 and 104 weeks of age and of three mouse models of accelerated aging: Ercc1 heart 
specific knock-out mice, Tert knock-out mice and mice harboring the Hq mutation characterized by haploinsuf-
ficiency of Aifm1 (Fig. 1a). A technical summary of the RNA-seq is reported in Table 1: for each group sample, an 
average of 100 million paired reads were generated, accounting for an alignment rate varying from a minimum 
of 74,4% for the Ercc1-deficient mouse model to a maximum of 81,7% for the Tert-deficient and the young, nat-
urally aged models. Of the paired reads, a percentage in-between 21,8% and 29,7% did not map concordantly 
to the genome, i.e. either the read pair maps discordantly or just one read of the pair maps to the genome, the 
63,5-70,8% of read pairs aligned concordantly only once and the 6,8-8,4% aligned concordantly more than once. 
In each group, ~32 million of reads were mapped to protein-coding gene loci, 14 to 20 million were mapped to 
lncRNA genes and 34–44 million were mapped to other regions of the genome.
The degree of cardiac dysfunction described for the mouse models of aging used in this study is remark-
ably varied: naturally aged and Tert-deficient mice share a relatively mild cardiac phenotype (mild eccentric 
remodeling, slight reduction in contractile function), Hq mice have slightly bigger hearts and a worsening in the 
response to ischemia/reperfusion injuries and Ercc1-deficient animals develop dilated cardiomyopathy. To assess 
the extent of this heterogeneity we chose to analyse the expression levels of the cardiomyocyte fetal genes Nppa 
and Nppb. In physiological conditions, postnatal expression of Nppa and Nppb is strongly downregulated; how-
ever, it gets drastically increased during adverse structural remodeling. The results of the Real-time PCR analysis 
of Nppa and Nppb are reported in (Fig. 1b,c): a significant up-regulation of Nppa was found only in the Hq model, 
although a similar trend is observed also for the hearts from Ercc1-deficient animals. As for Nppb, its expression 
is significantly increased only in the Ercc1-deficient model. However, neither Nppa nor Nppb are differentially 
expressed in the Tert-deficient and in the natural aging models. These results confirm the disparities in the cardiac 
phenotypes manifested by these models of senescence, with Ercc1-deficient and Harlequin mice having the most 
disease-like ones. Additionally, these data are suggestive of a remarkably healthy-like transcriptional profile of 104 
week-old naturally aged hearts, that we further investigated by comparing the mRNAs, lncRNAs and miRNAs 
differentially expressed between the three time-points of natural aging.
Starting from the protein-coding genes profiles, there was no clear separation between the transcriptomes 
of the murine hearts of different ages when looking at the first component of our principal component analysis 
(PCA); in fact, we could only detect mild intra-group variance accounting for expected small differences between 
biological replicates (Fig. 1d). Only when considering the second component, which describes just 13% of the 
variance between the samples, a separate clustering between the three time-points of aging became slightly more 
evident. Similarly, no detectable clustering of the three timepoints of natural aging could be detected when per-
forming the PCA on the lncRNA data (Fig. 1e). Our sequencing analysis provided us also with information on the 
miRNAs expressed in the hearts of naturally aging mice; however, when comparing the different time-points, we 
did not detect any differentially expressed miRNAs. Conclusively, the expression profiles of all the RNA biotypes 
we detected with our sequencing approach remained remarkably stable throughout the life span of naturally aged 
mice.
Quantitative differences in the transcriptomes between naturally- and accelerated aged 
hearts. Next, we characterized the transcriptomic profiles of three mouse models of accelerated aging: 
Ercc1 heart specific knock-out mice, Tert knock-out mice and mice harboring the Hq mutation characterized 
by haploinsufficiency of Aifm1 (Fig. 1a). Specifically, our interest was to verify the similarity of these accelerated 
aged models to their naturally aged counterpart. Our results demonstrate that the profiles of the accelerated 
aging models Ercc1-deficient and Hq markedly differ from the Tert-deficient model and naturally aged animals. 
Compared to the variation detected between the different models of accelerated aging, the transcriptome profiles 
of naturally aged mice of 12, 52 and 104 weeks of age cluster very close together, indicating that the differences 
in protein-coding gene expression profiles within these groups is considerably smaller than those between any 
of the models of premature senescence except for the Tert-deficient model (Fig. 2a). These observations sug-
gest a minimal similarity between the transcriptomes of naturally- and accelerated aging models, an unexpected 
finding considering that the prematurely aged models, per definition, were expected to manifest, at least in part, 
similar changes during physiological senescence but at an accelerated pace. Indeed, the transcriptomes of the 
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Figure 1. Experimental design and PCA plots of mRNAs and lncRNAs in the naturally aging model. (a) 
Experimental timeline followed for the collection of the heart tissues used for the RNA-sequencing. Real-
time PCR expression analysis of the cardiomyocytes stress genes (b) Nppa and (c) Nppb in hearts from mice 
modeling natural and premature senescence, n refers to number of hearts. PCA plots of the (d) mRNAs (e) 
lncRNAs data representing the expression profiles trends of the hearts of naturally aged mice of 12, 52 and 104 
weeks of age. The plots have been generated using the first two principal components, which together account 
for the (d) 50% and (e) 31% of the variance between samples, n = 4 hearts for each mouse model. NA12W, 
natural aging 12 week-old; NA52W, natural aging 52 week-old; NA104W, natural aging 104 week-old; *P < 0.05 
vs wild-type 12 week-old mice.
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Ercc1-deficient model and the Hq model, when compared to age-matched, wild-type mice, involved a much larger 
number of differentially expressed genes than those altered in the naturally aged mice (Fig. 2b). Even though a 
slight overlap in changes in expression levels of protein-coding transcripts could be detected between natural and 
accelerated aging, the modifications in the transcriptomes of the models of premature senescence were strikingly 
bigger and model-specific, suggesting that the biological processes involved in the pathophysiology of accelerated 
aging are most likely more numerous and more robustly altered. Among the premature senescence models, the 
Tert-deficient mouse model showed a transcriptome profile that was most similar to natural aging.
The same observations hold true when analyzing the expression profiles of lncRNAs (Fig. 3). LncRNA 
transcriptomes from the Ercc1-deficient and Hq models were more different compared to the natural aging 
and Tert-deficient models, whilst the latter tended to cluster close together (Fig. 3a). Even quantitatively, 
Ercc1-deficient Harlequin Tert-deficient NA12w NA52w NA104w
Single reads 58,573,980 57,188,219 58,083,642 56,299,051 55,973,585 59,310,196
Overall alignment rate 74,40% 79,20% 81,70% 81,70% 80,50% 80,60%
Pairs aligned concordantly 
0 times 29,70% 24,80% 21,80% 21,90% 23,10% 22,90%
Pairs aligned concordantly 
exactly 1 time 63,50% 66,80% 70,80% 70,60% 69,50% 69,40%
Pairs aligned 
concordantly > 1 times 6,80% 8,40% 7,40% 7,50% 7,40% 7,70%
Reads mapping to protein-
coding genes 3,24E + 07 3,20E + 07 3,45E + 07 3,18E + 07 3,13E + 07 3,43E + 07
LncRNA genes 2,04E + 06 1,36E + 06 1,54E + 06 1,47E + 06 1,46E + 06 1,48E + 06
Others 3,35E + 07 4,40E + 07 3,50E + 07 3,75E + 07 3,61E + 07 3,89E + 07
Table 1. Technical summary of the RNA-seq mapping results.
Figure 2. MRNA expression profiles in the natural and premature aging models. (a) PCA plot summarizing 
the trends in the mRNA expression profiles of the hearts of the different models of senescence. The plot has 
been generated using the first two principal components, which together account for the 44% of the variance 
between samples, n = 4 hearts for each mouse model. (b) VENN diagram showing the number of significantly 
differentially expressed mRNAs in each aging model in comparison to the wild-type youngest timepoint. 
NA12W, natural aging 12 week-old; NA52W, natural aging 52 week-old; NA104W, natural aging 104 week-old.
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the alterations in lncRNAs in the Ercc1-deficient and Hq models involved a considerable larger number of tran-
scripts than those observed for the Tert-deficient model or in naturally senescent animals. Moreover, the majority 
of the differentially expressed lncRNAs were altered in a model-specific manner, supporting the contention that 
in each model distinct pathophysiological processes are operative (Fig. 3b).
Taken together, our findings point to a stark disparity between the transcriptomes of the three different accel-
erated aging models, which, additionally showed marked dissimilarities when compared to the transcriptome of 
naturally aging animals.
Dramatic changes in the transcriptome of Harlequin mouse hearts. Among the models of prema-
ture senescence, the Harlequin model is particularly interesting to study the aging process in general, given the 
variety and severity of the phenotype developed in this model, and of the heart in particular, given the crucial role 
that intrinsic oxidative stress plays in the genesis of senescence. As previously stated, we observed that the hearts 
of naturally aged mice maintain a relatively stable transcriptome over time; indeed, only 314 protein-coding 
genes were differentially expressed between 12 and 104 week-old hearts, of which 274 were downregulated and 
40 upregulated (Fig. 4a). These numbers are dwarfed when compared to the number of genes altered in the Hq 
model: 1763 in total, of which 867 genes were downregulated and 896 were upregulated (Fig. 4a).
This dichotomy became even more evident when differentially expressed lncRNAs were considered (Fig. 4c). 
The numbers of lncRNAs significantly altered in expression in the young versus old naturally aged hearts were 
extremely low (11 in total, of which 9 downregulated and 2 upregulated), while a total of 383 lncRNAs were differ-
entially expressed in Hq hearts, of which 215 were downregulated and 168 were increased in expression.
We validated the RNA sequencing data by performing Real-time PCR analysis of targets selected among the 
most differentially regulated protein-coding transcripts and lncRNAs in both group comparisons (Fig. 4b,d). Our 
sequencing results are strongly supported by Real-time PCR data since we confirmed the same trends of expres-
sion in a statistically significant way.
Figure 3. LncRNA expression profiles in the natural and premature aging models. (a) PCA plot summarizing 
the lncRNA expression profiles of the hearts of the different models of senescence. The plot has been generated 
using the first two principal components, which together account for the 34% of the variance between samples, 
n = 4 hearts for each mouse model. (b) VENN diagram showing the number of significantly differentially 
expressed lncRNAs in each aging model resulting from the comparison to the wild-type youngest timepoint. 
NA12W, natural aging 12 week-old; NA52W, natural aging 52 week-old; NA104W, natural aging 104 week-old.
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Taken together, these results underline that the transcriptome during natural aging remains stable, which 
contrasts to the dramatic alterations found in the expression profile of hearts from Hq mice.
The transcriptomes of accelerated aging models diverge from natural aging. Next, the grade 
of transcriptome overlap between the distinct models of senescence was analyzed. In theory, as models of the 
Figure 4. Representation of the differences in the expression profiles between selected group comparisons. 
Volcano plots reporting the differentially expressed (a) mRNAs and (c) lncRNAs in the hearts of naturally 
aged and Harlequin mice compared to wild-type 12 week-old animals. In blue and yellow are the down- and 
up-regulated genes respectively. (b-d) Real-time PCR analysis of selected targets validates the RNA-sequencing 
results. *P < 0.05 vs wild-type 12 week-old mice; n refers to number of hearts.
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same process, their expression profiles were expected to be largely overlapping. Surprisingly, our results depict 
radical differences between the various models. Figure 5a depicts the normalized z-scores of the count data in all 
premature aging models of the 50 most differentially regulated protein-coding genes found in the comparison 
between young and old naturally aged hearts. As expected, the expression pattern of 52 weeks old hearts was an 
intermediate version of the young and old hearts. More unexpectedly, the data further shows that the models of 
premature aging are either clustering with the young (Tert-deficient) or adult (Ercc1-deficient, Hq) natural aging 
timepoints rather than with old one. The same observations hold true when analysing the fold changes of the 
lncRNAs in all aging models (Fig. 6a). 52 week-old hearts manifest an intermediate pattern compared to young 
(12 weeks) and old (104 weeks) hearts and the transcriptomes of the prematurely aged models cluster closer with 
the young and intermediate aged hearts rather than with the eldest time point.
This discordance between naturally- and accelerated aged cardiac transcriptomes became even more evi-
dent from the heatmaps representing the 50 most altered protein-coding genes (Fig. 5b) and lncRNAs (Fig. 6b) 
resulting from the primary comparison between Hq and age-matched naturally aged hearts. The same heatmaps 
also report the level of expression of the same transcripts in the other aging models. For both protein-coding 
genes and lncRNAs, the transcriptome of the Hq model stands clearly apart from all time-points of natural aging 
and also differs greatly from that of Tert-deficient mice, while being relatively similar to Errc1-deficient animals 
(Fig. 5b, Fig. 6b). Interestingly, the majority of most dysregulated genes in the hearts of Hq mice are not or only 
mildly altered in the other models, confirming that the genomic alterations observed are specifically occurring in 
response to the Hq mutation. As an additional layer of information, we gathered in (Supplementary Tables 2,3) 
the list of protein-coding genes within 1Mbp from the loci of the lncRNAs reported in (Fig. 6); this can provide 
meaningful information for cis-acting lncRNAs.
Taken together, these data demonstrate an unexpectedly limited overlap of the transcriptomes of accelerated 
aged models between each other and reinforce the contrast with the senescent, naturally aged animals.
Functional enrichment analysis of the aging models confirms their biological dichotomy. 
Finally, we explored the biological processes affected by the alterations in gene expression observed in each of 
our aging models. Accordingly, we first performed a GO-terms enrichment analysis considering the top 100 
differentially expressed protein-coding genes between the accelerated aging models and their young reference 
wild-type counterpart. Separately, we also considered a GO-terms enrichment of genes altered between young 
and old naturally aged animals. On the basis of these gene expression patterns, we performed the analysis for the 
enriched GO terms belonging to the Biological Process (BP) category. The dot-blot visualizes the results for the 
top 5 enriched GO terms for every group comparison and the most altered biological processes in each model 
(Fig. 7a). Remarkably, the biological processes altered in each model were non-overlapping. Specifically, of the 
18 GO terms included in the graph, those enriched in naturally aged animals related to the immune reactivity 
Figure 5. Heatmaps of differentially expressed mRNAs. Heatmaps of the 50 most differentially regulated 
mRNAs resulting from the comparison between (a) young and old naturally aged hearts and between (b) the 
Harlequin model with its age-matched counterpart; the normalized z-scores of the count data are shown for all 
the aging models used, n = 4 hearts for each mouse model.
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and complement activation, an observation in agreement with the concept of immunosenescence, the decline of 
innate and adaptive immune responses occurring with age, a phenomenon extensively described in literature36,37. 
The GO terms enriched for the Ercc1-deficient model mostly specify for extracellular matrix organization and 
collagen fibril assembling, reflecting the fibrotic tissue deposition accompanying dilated cardiomyopathy, which 
develops in the hearts of Ercc1-deficient animals. For Hq, the GO terms most enriched are those referring to chro-
mosome condensation and DNA packaging, possibly reflecting the damaging effect of reactive oxygen species on 
DNA integrity38.
Next, we created a cnet plot to visualize the individual genes underlining the biological phenomena found 
altered in naturally aged hearts: C1s1, C1ra, C4b and C3, responsible of the regulation of the complement cas-
cade, were found differentially expressed, as well as limited numbers of Serpin genes (e.g. Serpina3i, Serpina3n, 
Serpine1), implicating fibrinolysis and platelet degranulation in the natural aging of the myocardium (Fig. 7b). 
When juxtaposing these results with the cnet plot generated for the Hq model, the difference in the number of 
genes implicated was striking (Fig. 7c). Here, numerous genes formed clustered networks revolving around Rho 
GTPase activity (e.g. Cdc8a, Iqgap3), chromatin remodeling (e.g. Hist1h2a1, Hist1h4m, Hist1h3g) and nuclear 
signaling cascades (e.g. Lef1, Ywhah). Likewise, matrix and transmembrane constituents (Tuba1a, Fn1, Itga2b), 
several protein kinase C isoforms (Prkcg, Prkacb, Prkch), cardiac-specific cytoskeletal components (Tln1, Actn4) 
as well as intracellular signaling mediators (Pde5a, Pde11a), also known for their effect on platelet function, were 
found as central nodes of the Hq network.
The GO terms higlighted in this analysis can be efficiently contextualized within the unique phenotypes of 
each aging model, suggesting that the biological processes that were altered in each model are not driving them 
more closely to the natural aging condition, but rather generate an exclusively pathological state strictly correlat-
ing to the mutation that has been introduced by the generation of the model itself.
Discussion
Here, we provided a description of the changes in the transcriptome of the murine heart during aging. To this 
end, we analysed by RNA-seq the cardiac expression profiles of protein-coding and non-coding genes in natu-
rally aging mice of 12, 52 and 104 weeks of age and in three different mouse models of accelerated aging, each 
characterized by the alteration of one of the pathways regarded in literature as crucial contributors to senescence. 
Specifically, we included mice with cardiac-specific deficiency of Ercc1, encoding a component of the DNA repair 
machinery, Hq mice with reduced mitochondrial antioxidant capacity and Tert-deficient mice with reduced tel-
omere length.
A first, striking result emerging from our analysis is that the transcriptomes of the models of premature 
senescence dramatically differ from each other and from the reference wild-type counterpart. Although arising 
from alterations of different biological processes, the accelerated aging models should display a similar “aging 
Figure 6. Heatmaps of differentially expressed lncRNAs. Heatmaps of the 50 most differentially regulated 
lncRNAs resulting from the comparison between (a) young and old naturally aged hearts and between (b) the 
Harlequin model with its age-matched counterpart; the normalized z-scores of the count data are shown for all 
the aging models used, n = 4 hearts for each mouse model.
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behavior”, since the pathways that have been mutated to generate these models are all extensively reported in 
literature as contributing to senescence. Accordingly, even if genetically different, these models should ultimately 
reproduce the same phenomena and manifest in a shorter period of time what results from a lifetime of intrinsic 
and extrinsic insults in a naturally aged animal. In stark contrast, our results depict a different scenario: from the 
perspective of their transcriptomes, not only do the accelerated aging models largely differ from the eldest time 
point of natural aging but they also show specific features that set each model apart from the rest. One possible 
explanation is that the extent of the alteration caused when genetically manipulating these animals is so dramatic 
to produce a pathological outcome rather than a physiological phenotype resembling the one observed at old 
age. Ultimately, this leads to the conclusion that each of these models is manifesting the pathology caused by the 
impairment of a certain cellular pathway and not an accelerated aged phenotype produced by aggravating one of 
the proposed molecular causes of senescence.
A second and arguably even more controversial aspect highlighted by our results is that naturally aging mice 
do not display large changes in their cardiac gene expression profiles over time. As widely reported in literature, 
a commonly used animal model to study aging is the mouse; accordingly, we tackled physiological senescence by 
considering mice at three stadia, 12, 52 and 104 weeks of age, so to have a comprehensive overview of the murine 
transcriptome over its lifespan. In contrast to our expectations, we observed a surprisingly stable expression of 
Figure 7. Functional enrichment analyses of aging models. (a) GO-terms enrichment analysis using the 
differentially expressed mRNAs in each aging model after the comparison with wild-type 12 week-old mice. 
Gene-Concept networks visualizing the individual protein-coding genes associated to the GO-terms found 
enriched for (b) naturally-aged and (c) Harlequin mice.
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protein-coding genes and lncRNAs and, when considering miRNAs, we were not able to detect any differentially 
expressed transcript over time. We tend to exclude that the reason for these observations is the choice of a too pre-
mature age for the eldest timepoint of our study, as 24 months is supported by previous reports as a representative 
old age in mice in the context of cardiac senescence39,40. Our findings point instead to the conclusion that the phe-
nomenon of physiological aging in the murine heart fails to recapitulate myocardial aging as observed in humans. 
Supporting this hypothesis is the fact that laboratory mice do not display a higher incidence of cardiac diseases 
nor typical age-related comorbidities as their natural cause of death but rather succumb from neoplasia with a 
very rare incidence of cardiovascular abnormalities41,42. Conversely, in humans, as reported by the World Health 
Organization (WHO), of the 56.9 millions deaths worldwide in 2016, 15.2 millions where caused by ischemic 
heart disease and stroke. The translational value of laboratory mice to model advanced age-related human heart 
diseases is, therefore, debatable.
There are three main limitations to the current study. First, the degree of cardiac dysfunction described for the 
aging mouse models in this study is remarkably variable. The naturally aged and the Tert-deficient mouse models 
share a relatively mild cardiac phenotype (mild eccentric remodeling, slight reduction in contractile function), 
Harlequin-deficient mice show spontaneous hypertrophic remodeling, while the Ercc1-deficient model displays 
a severe dilated cardiomyopathy at the age analyzed14,16,29. These models were previously characterized in terms 
of hemodynamic assessment and myocardial histopathology and these analyses were not repeated in this study 
for logistical reasons. Nevertheless, despite the lack of a direct coupling of our RNA-seq data with pathophysio-
logical characterization, we could confirm the disparities in the cardiac phenotypes manifested by these models 
of senescence by assessing transcript abundance of the genes Nppa and Nppb, robust markers of adverse structural 
remodeling.
Secondly, in this study we relied on bulk RNA-sequencing that integrates transcriptomic information across 
thousands of cells and results in averaged gene expression levels. Although an average expression level for each 
gene in the cell population can be sufficient in many applications, such as to determine disease biomarkers or to 
compare the overall transcriptomic differences between disease states, as performed in the current study, bulk 
RNA-seq analysis lacks the detail of cell-specific functionality within a specific model. The adult murine myo-
cardium is composed of approximately 30% myocytes, 40% endothelial cells, 15% hematopoietic-derived cells 
and 15% fibroblasts. Bulk RNA-seq lacks of cellular resolution, which might account for possible differences 
with other studies using purified myocardial cells43. For a future in-depth analysis, the diverse cell types of each 
model in this study could be sequenced, but this endeavour falls beyond the scope of the current study.
A third potential limitation relates to the genetic background of the mouse strains used. In the most optimal 
scenario, all models would have been of the exact same, pure inbred background. For practical reasons, the hybrid 
background B6129F1 for the naturally aging mouse strain was deliberately chosen as only this hybrid strain 
shows signs of cardiac dysfunction and interstitial fibrosis at advanced ages (e.g. 24 months) as opposed to the 
age-resistant pure inbred C57BL6/J strain14. To correct for slightly altered differences in the transcriptome due to 
background differences, strain- and organ-specific gene expression profiles would need to be generated and later 
integrated into RNA-seq pipelines to filter and normalize the sequencing results on the basis of these patterns. 
This kind of analysis has been repoted for a select number of inbred strains, but not for the hybrid strains used in 
this study44. Studies aimed at unraveling strain-specific gene expression profiles were indeed able to find differ-
ences at the genomic (SNPs), transcriptomic (mRNA) and proteomic levels but failed to trace them on all levels 
simultaneously45,46. For example, Parks and coworkers showed 160 differential strain specific expressed proteins 
when comparing C57BL/6 J and DBA/2 J inbred mouse strains. However, of those only 26% showed significant 
strain differences at the mRNA level whilst the 76% demonstrated the same strain effect direction45. These results 
lead us to the assumption that, although different strain background could have an influence when being com-
pared, their influence should be irrelevant when comparing model-specific effects as performed in this study.
Based on our findings, we speculate that a more appropriate murine model of human cardiac aging would 
include vascular diseases (e.g. atherosclerosis), possibly in combination with high blood pressure and metabolic 
disorders. One strategy for the generation of such a model would be to introduce the comorbidities that are fre-
quently observed among elderlies but absent in laboratory mice. The incidence of cardiovascular risk factors, such 
as high blood pressure and metabolic syndrome, hyperlipoproteinemia and type 2 diabetes, sharply increase with 
age among humans; mice, on the contrary, rarely spontaneously manifest these comorbidities. This difference 
could account for the disparity between mouse and human cardiac aging, although this contention would require 
a side-by-side confirmation of a similar transcriptomic analysis of human hearts over their lifespan. Conclusively, 
our study proposes controversial points of discussion on the reliability of the most commonly used murine aging 
models to study human cardiac senescence.
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